AzTrials
AzTrials

Mental FatigueNCT02895997

Turning Night Into Day: Transcontinental Provision of Telehealth By and For the Emory Community

A study testing Travel Telehealth Delivery in people with Mental Fatigue, run by Emory University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to determine if temporarily relocating clinicians who deliver remote care using the eICU telehealth system to Sydney, Australia will lead to greater job satisfaction, reduced physiologic stress, and improve performance. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mental Fatigue
What is being tested?
Travel Telehealth Delivery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteUnited States
Study dates
Jul 2016to 31 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinicians working in the clinical operations room at Emory University Hospital who volunteer participation in the study

Who cannot join

  • Declining to participate after the first phase of data collection

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Emory University

    Atlanta, Georgia, 30322

Other trials in United States

About this study

The purpose of the study is to determine if temporarily relocating clinicians who deliver remote care using the eICU telehealth system to Sydney, Australia will lead to greater job satisfaction, reduced physiologic stress, and improve performance. Four nurses and six physicians will be sent to a site in Sydney Australia on a rotating basis to determine whether providing care during the Australian daytime is more efficient and precise than providing care during the night in the United States.

Read the detailed description

The purpose of the study is to determine if temporarily relocating clinicians who deliver remote care using the eICU telehealth system to Sydney Australia will lead to greater job satisfaction, reduced physiologic stress, and improve performance. Four nurses and six physicians will be sent to a site in Sydney Australia on a rotating basis to determine whether providing care during the Australian daytime is more efficient and precise than providing care during the night in the United States.

As part of this pilot, each participant will undergo a series of evaluations before leaving, while in Australia, and after returning. The evaluations will include questionnaires related to well-being, task assessment (such as completing a paper maze or performing arithmetic), physiology assessment (such as continuous measure of heart rate by a wristwatch type device), and stress assessment (by sampling saliva and measuring cortisol and interleukin-1 Beta).

The researchers would like to determine whether normalization of the provider's (physician or nurse who are the research subjects) sleep-wake cycle improves subjective and objective well-being. Additionally, investigators seek to determine whether normalization of the provider's (physician or nurse who are the research subjects) sleep-wake cycle improves alertness and focus, and determine whether normalization of the provider's (physician or nurse who are the research subjects) sleep-wake cycle improves job performance.

Conditions
Mental Fatigue
Being tested
Travel Telehealth Delivery
Keywords
mental fatigue, critical care
Medical subject headings
Mental Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Travel Telehealth DeliveryOther

    Clinical Operations Room (COR) staff will travel to Sydney Australia to deliver telehealth to patients in Georgia United States. Upon arrival, participants will have eight nights and seven days free of clinical responsibilities. Thereafter, each participant will work four consecutive days of 12 hour shifts followed by four consecutive days with no clinical assignment. The following week, participants will work three consecutive days of 12 hour shifts followed by four consecutive days with no clinical assignment. Upon return to the USA, participants will have a week free of clinical responsibilities.

Study groups in NCT02895997
Study groupRoleWhat they receive
Clinical Operations Room StaffExperimentalClinicians and critical care nurse volunteers from the clinical operations room (COR) staff at Emory University Hospital will travel to Sydney Australia to deliver telemedicine.
Receives: Other: Travel Telehealth Delivery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Salivary Cortisol Levels

    Saliva will be collected via a mouth swab and tested for cortisol levels. Cortisol is a stress biomarker.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

Secondary outcomes (18)
  1. Change in Stanford Sleepiness Scale Score

    The Stanford Sleepiness Scale is a seven point scale that asks participants to assess how alert they are feeling throughout the day. A result of 4 or below may indicate that a participant could be suffering from a lack of sleep

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  2. Change in the Trail Making Test A Score

    During the Trail Making Test A, participants will be asked to draw lines to connect circled numbers in a numerical sequence (i.e., 1-2-3, etc.) as rapidly in possible. A shorter time indicates better cognition.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  3. Change in the Trail Making Test B Score

    During the Trail Making Test B, participants will be asked to draw lines to connect circled numbers and letters in an alternating numeric and alphabetic sequence (i.e., 1-A-2-B, etc.) as rapidly as possible. A shorter time indicates better cognition.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  4. Change in Physical Activity assessed by Multi-Scale Entropy

    Multi-scale entropy will be measured using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  5. Change in Physical Activity assessed by Multi-Scale Complexity

    Multi-scale complexity will be measured using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  6. Change in Heart Rate Variability assessed by Deceleration Capacity

    Deceleration capacity will be measured using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  7. Change in Heart Rate Variability assessed by Acceleration Capacity

    Acceleration capacity will be measured using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  8. Frequency of Arrhythmias

    The frequency of arrhythmias will be collected using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Duration of Study (Up to 31 Days)

  9. Change in Sleep Latency

    Sleep latency is the length of time it takes to accomplish the transition from full wakefulness to sleep. This will be measured in minutes using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  10. Number of Awakenings per Hour

    The number of times a participants awakes during sleep will be monitored at every hour using a Jawbone wristband device provided to participants upon enrollment.

    Measured: Duration of Study (Up to 31 Days)

  11. Change in Percent of Non Rapid Eye Movement (REM) Sleep

    Change is the difference between the percentage of non REM sleep taken during performance phases.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  12. Change in Mood Symptom Questionnaire Score

    The Mood Symptom Questionnaire was originally designed to diagnose bipolar disorder. The questionnaire takes about five minutes to complete, and can provide important insights into diagnosis and treatment.If the patient answers "Yes" to seven or more of the 13 items in question number 1 AND "Yes" to question number 2 AND "Moderate" or "Serious" to question number 3, there is a positive screen.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  13. Change in Patient Health Questionnaire-9 (PHQ-9) Score

    The PHQ-9 is a multi-purpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. A score of 5-9 represents signs of minimal depression symptoms. A score of 10-14 represents symptoms of minor depression. A score of 15-19 represents symptoms of major depression, moderately severe. A score of greater than 20 represents symptoms of major depression, severe.

    Measured: Baseline, Post Intervention (Up to 8 weeks)

  14. Change in Number of Camera Sessions

    Difference in the number of camera sessions completed during performance phases.

    Measured: Day 1, Day 31

  15. Change in Duration of Camera Sessions

    Difference in the duration of camera sessions during performance phases measured in minutes.

    Measured: Day 1, Day 31

  16. Change in Urgency of Clinical Contacts

    Difference in priority levels assigned to each clinical contact (levels: preventative; informative/procedural; urgent; life-threatening)

    Measured: Day 1, Day 31

  17. Change in Number if Clinical Record Entries

    Difference in the number of clinical record entries made by physicians only during the performance phases.

    Measured: Day 1, Day 31

  18. Change in Duration of Service

    Difference in the duration of physician services during each performance phase measured in hours.

    Measured: Day 1, Day 31

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2016 (estimated)
  2. Study startJul 2016
  3. Primary completion31 Dec 2017
  4. Study completion31 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02895997
Sponsor's protocol ID
IRB00088367
Status last verified
Nov 2018
First submitted
1 Sep 2016
Last updated
20 Nov 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared with future researchers.

Questions about this trial

What is this clinical trial studying?

A study testing Travel Telehealth Delivery in people with Mental Fatigue, run by Emory University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Salivary Cortisol Levels (time frame: Baseline, Post Intervention (Up to 8 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in